Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

NJEAS. 2023; 1(1): 0-0


In vitro Detoxifying Effects of Catunaregam nilotica(STAPF) Root Extracts against Naja nigricollis Phospholipase A2 (PLA2) Enzyme

Mustapha Salihu,Lawal Gusau Hassan,Umar Zaki Faruq,Amina Jega Yusuf.




Abstract

Snakebite is a severe public health problem across the globe, especially in sub-Saharan Africa where most victims live in rural areas where their livelihood depends on farming and rearing animals. Catuneragamniloticahas been used in ethnomedicine to treat snakebites, and diarrhea among others. The study aims to evaluate the phospholipase A2 inhibition potential of C. niloitca using in vitro model. The plant was collected, authenticated, and sequentially extracted using solvents of increasing polarity starting from n-hexane, ethyl acetate, and methanol. The extracts were screened in vitro for their inhibitory activity against N. nigricollisvenom using PLA2 assay, and polyvalent serum-base antivenin was used as a standard. The phytochemical screening conducted using standard procedures revealed the presence of flavonoids, alkaloids, saponins, polyphenols, tannins, terpenoids, cardiac glycosides, anthraquinones, and steroids which varies in the extracts. The extracts of the plant have demonstrated significant (p

Key words: Catuneragam nilotica, antivenin, phospholipase A2, phytochemicals, Naja nigricollis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.